DARYL GAUGLER - 05 Feb 2024 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Signature
/s/ Kristen Williams, Attorney-in-Fact
Issuer symbol
PCRX
Transactions as of
05 Feb 2024
Net transactions value
$0
Form type
4
Filing time
07 Feb 2024, 16:59:39 UTC
Previous filing
16 Jun 2023
Next filing
05 Jun 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Award $0 +33,700 +106% $0.000000 65,494 05 Feb 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that vest on February 1, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
F2 Includes 135.988 shares of common stock acquired under the issuer's employee stock purchase plan in December 2023.